Quarterly report pursuant to Section 13 or 15(d)

Interim Segment Information (Tables)

v3.20.4
Interim Segment Information (Tables)
 9 Months Ended
Dec. 31, 2020
Segment Reporting [Abstract]  
Segment information
Segment information for the three and nine months ended December 31, 2020, and 2019, is set forth below: 
Three months ended December 31, 2020
(in thousands) IBW ISM CNS Total
Revenue $ 1,648  $ 2,677  $ 3,324  $ 7,649 
Cost of revenue 1,564 

1,242  2,637  5,443 
Gross profit 84  1,435  687  2,206 
Gross margin 5.1  % 53.6  % 20.7  % 28.8  %
Research and development 404  409  193  1,006 
Segment profit $ (320) $ 1,026  $ 494  1,200 
Operating expenses:
Sales and marketing 1,200 
General and administrative 863 
Intangible amortization 226 
Operating profit (loss) (1,089)
Other income, net 178 
Income tax benefit (expense) (23)
Net income (loss) $ (934)
Three months ended December 31, 2019
(in thousands) IBW ISM CNS Total
Revenue $ 2,466  $ 2,456  $ 2,237  $ 7,159 
Cost of revenue 1,657  991  1,731  4,379 
Gross profit 809  1,465  506  2,780 
Gross margin 32.8  % 59.6  % 22.6  % 38.8  %
Research and development 470  505  247  1,222 
Segment profit (loss) $ 339  $ 960  $ 259  1,558 
Operating expenses:
Sales and marketing 1,556 
General and administrative 1,093 
Intangible amortization 308 
Restructuring 234 
Operating profit (loss) (1,633)
Other income, net 109 
Income tax benefit (expense) (20)
Net income (loss) $ (1,544)
  Nine months ended December 31, 2020
(in thousands) IBW ISM CNS Total
Revenue $ 7,618  $ 6,632  $ 9,069  $ 23,319 
Cost of revenue 5,300 

3,017  7,163  15,480 
Gross profit 2,318  3,615  1,906  7,839 
Gross margin 30.4  % 54.5  % 21.0  % 33.6  %
Research and development 1,068  1,195  602  2,865 
Segment profit $ 1,250  $ 2,420  $ 1,304  4,974 
Operating expenses:
Sales and marketing 4,024 
General and administrative 3,175 
Intangible amortization 677 
Operating profit (loss) (2,902)
Other income, net 223 
Income tax benefit (expense) 35 
Net income (loss) $ (2,644)
Nine months ended December 31, 2019
(in thousands) IBW ISM CNS Total
Revenue $ 8,007  $ 8,197  $ 7,526  $ 23,730 
Cost of revenue 5,813  4,111  6,201  16,125 
Gross profit 2,194  4,086  1,325  7,605 
Gross margin 27.4  %

49.8  % 17.6  % 32.0  %
Research and development 1,272  1,825  1,130  4,227 
Segment profit (loss) $ 922  $ 2,261  $ 195  3,378 
Operating expenses:
Sales and marketing 6,147 
General and administrative 3,706 
Intangible amortization 924 
Restructuring 234 
Operating profit (loss) (7,633)
Other income, net 398 
Income tax benefit (expense) (27)
Net income (loss) $ (7,262)